MedPath

Early Versus Late Amniotomy Following EAB Cervical Ripening

Not Applicable
Terminated
Conditions
Induction of Labor Affected Fetus / Newborn
Interventions
Other: Amniotomy
Registration Number
NCT04216628
Lead Sponsor
Assuta Ashdod Hospital
Brief Summary

The objective of this study is to investigate the course of labor in early versus late amniotomy following balloon cervical ripening in women undergoing term induction of labor stratified by parity.

Detailed Description

Induction of labor is a common obstetric procedure with a reported rate of 23.3% in 2012 in the United State. It has been recently reported that Induction of labor at full term in uncomplicated singleton gestations is not associated with increased risk of cesarean delivery and overall has similar outcomes compared to expectant management.

Induction of labor in women with an unripened cervix is comprised of two stages, cervical ripening followed by augmentation of labor.

Extra amniotic balloon inflation is a widespread mechanical method of cervical ripening that commonly results in a ripened cervix open to 3-4 cm without significant uterine contractions. At this point the clinician may opt to perform artificial rupture of membranes or rather first begin oxytocin infusion delaying amniotomy to later stages of labor. A retrospective cohort showed early amniotomy after Foley balloon catheter removal was associated with shorter duration of labor induction among nulliparous women.In accordance, an RCT investigating the efficacy of early amniotomy in nulliparous women showed this practice resulted in labor shortening without increasing the rate of cesarean section, yet these women were treated by different methods for cervical ripening. Contradicting results were shown in a randomized controlled trial addressing the very question of early versus late amoniotomy after balloon ripening, concluding that postponing amniotomy until active labor commences results in a reduction of dystocia indicated cesarean section. However no distinction was made in this study between nulliparous and multiparous parturients. Since these comprise different groups with distinct labor curves, the question remains whether one should consider parity when deciding to perform early vs late amniotomy following balloon expulsion.

Both Amniotomy and Oxytocine infusion are part of the routine protocol and necessary procedures for induction of labor. Adverse outcome of amniotomy includes fetal heart rate changes, cord prolapse and intrapartum fever when labor is prolonged. Adverse outcome of oxytocine include hypertonus and fetal heart rate changes requiring cessation of oxytocine infusion (as in routine protocol) and intrapartum fever if labor is prolonged (not due to oxytocine infusion per se). Most of the patients admitted for induction of labor will need both amniotomy and oxytocine, however the role of the order of these two procedures is unclear ,as well as whether the order of these procedures affect the rate of adverse outcome.

The objective of this study is to investigate the course of labor in early versus late amniotomy following balloon cervical ripening in women undergoing term induction of labor stratified by parity.

STUDY PROTOCOL Multicenter randomized control trial that will be conducted in 4 medical centers in Israel.

Women with a singleton viable gestation undergoing indicated labor induction at term (37-42 weeks of gestation) who undergoing induction of labor at term with a low bishop score\<4 who require extra amniotic balloon cervical ripening will be asked to participate in the study. Written informed consent will be obtained from all patients.

Early amniotomy- Amniotomy performed as the exclusive primary intervention to augment labor following expulsion of the EAB regardless of cervical dilatation.

Late amniotomy- EAB expulsion is followed by oxytocin infusion at increasing increments as the primary intervention as an exclusive intervention for at least 2 hours.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
146
Inclusion Criteria
  1. Gestational age 37-42 weeks
  2. Singleton pregnancy
  3. Vertex presentation
  4. Medical indication for induction of labor
  5. Need for cervical ripening (Bishop score <=6)
  6. Consent to participate in the study
  7. Women age at or >18 years
Exclusion Criteria
  1. Multiple pregnancies
  2. Preterm pregnancy
  3. Previous cesarean section
  4. Uterine malformation
  5. Withdrawal of consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Late amniotomy groupAmniotomyOxytocin infusion will begin as per local standard dose protocol. Amniotomy will be performed no earlier than 2 hours following the commence of oxytocin infusion
Early amniotomy groupAmniotomyAmniotomy will be performed as the exclusive primary intervention. Oxytocin infusion will begin as per local standard dose protocol no earlier than 2 hours following amniotomy.
Primary Outcome Measures
NameTimeMethod
Delivery within 24 hoursUp to 96 Hours

The proportion of women that delivered within 24 hours of induction

Time to deliveryUp to 96 Hours

The time from induction defined as the primary intervention following balloon expulsion to delivery.

Secondary Outcome Measures
NameTimeMethod
Operative deliveryUp to 96 Hours

Operative delivery rates and indications

Intrapartum feverUp to 96 Hours

Fever \>38 degrees Celsius during labor

Cesarean deliveryUp to 96 Hours

Cesarean delivery rates and indications

Post partum hemorrhageUp to 7 days

Estimation of obstetrician \>500cc bleeding post partum for vaginal delivery or\>1000 cc at cesarean section

Neonatal outcomes- Apgar10 minutes

Apgar score

Postpartum fever during the postpartum hospital stayUp to 7 days

Fever \>38 degrees Celsius \> 24hours after delivery

Neonatal outcomes- infectionUp to 30 days

Neonatal fever/sepsis

Neonatal outcomes - PH umbilical10 minutes

PH of vein and or artery of umbilical cord

Neonatal outcomes- NICU admissionUp to 30 days

Admission to Neonatal Intensive Care Unit

Trial Locations

Locations (1)

Assuta Ashdod

🇮🇱

Ashdod, Israel

© Copyright 2025. All Rights Reserved by MedPath